Publications Database

Akkök F. (1995)

The effects of naltrexone in autistic children: report of two cases.

Turkish Journal of Pediatrics

37(1), pp. 19-23

Read Abstract (New Window)

Anderson S. et al. (1997)

The effectiveness of naltrexone in treating task attending, aggression, self-injury, and stereotypic mannerisms of six young males with autism or pervasive developmental disorders.

Journal of Developmental and Physical Disabilities

9(3), pp. 211-221

Read Abstract (New Window)

Barrett R. P. , Feinstein C. , Hole W. T. (1989)

Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.

American Journal of Mental Retardation

93(6), pp. 644-651

Read Abstract (New Window)

Benjamin S. et al. (1995)

Case study: paradoxical response to naltrexone treatment of self-injurious behavior.

Journal of the American Academy of Child and Adolescent Psychiatry

34(2), pp. 238-242

Read Abstract (New Window)

Black S. L. et al. (1994)

Naltrexone in infantile autism.

Journal of Autism and Developmental Disorders

24(2), pp. 236-239

Read Extract (New Window)

Bouvard M. P. et al. (1995)

Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.

Psychiatry Research

58(3), pp. 191-201

Read Abstract (New Window)

Brown N. , Panksepp J. (2008)

Low-dose naltrexone for disease prevention and quality of life.

Medical Hypotheses

72(3), pp. 333-337

Read Abstract (New Window)

Buitelaar J. K. , Willemsen-Swinkels S. H. , van Engeland H. (1998)

Naltrexone in children with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

37(8), pp. 800-802

Buzan R. et al. (1995)

The use of opiate antagonists for recurrent self-injurious behavior.

Journal of Neuropsychiatry and Clinical Neurosciences

7(4), pp. 437-444

Read Abstract (New Window)

Campbell M. et al. (1990)

Naltrexone in autistic children: a double-blind and placebo-controlled study.

Psychopharmacology Bulletin

26(1), pp. 130-135

Read Abstract (New Window)

Campbell M. et al. (1989)

Naltrexone in autistic children: an acute open dose range tolerance trial.

Journal of the American Academy of Child and Adolescent Psychiatry

28(2), pp. 200-206

Read Abstract (New Window)

Campbell M. et al. (1993)

Naltrexone in autistic children: behavioral symptoms and attentional learning.

Journal of the American Academy of Child and Adolescent Psychiatry

32(6), pp. 1283-1291

Read Abstract (New Window)

Campbell M. (1998)

Naltrexone in infantile autism.

Psychopharmacology Bulletin

24(1), pp. 135-139

Cazzullo A. et al. (1999)

Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children.

European Neuropsychopharmacology

9(4), pp. 361-366

Read Abstract (New Window)

Deutsch S. I. (1986)

Rationale for the administration of opiate antagonists in treating infantile autism.

American Journal of Mental Deficiency

90(6), pp. 631-635

Read Abstract (New Window)

Dove D. et al. (2012)

Medications for adolescents and young adults with autism spectrum disorders: A systematic review.

Pediatrics

130(4), pp. 717 -726.

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Eissa N. et al.

Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder.

Frontiers in Neuroscience

Read Full (New Window)

ElChaar G. M. et al. (2004)

Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.

Mental Retardation and Developmental Disabilities Research Reviews

10(3), pp. 193-200.

Read Abstract (New Window)

Ernst M. et al. (1993)

Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.

Psychopharmacology Bulletin

29(2), pp. 221-227

Read Abstract (New Window)